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Abstract
PrfA is a key regulator of Listeria monocytogenes pathogenesis and induces the expression of multiple virulence factors
within the infected host. PrfA is post-translationally regulated such that the protein becomes activated upon bacterial entry
into the cell cytosol. The signal that triggers PrfA activation remains unknown, however mutations have been identified
(prfA* mutations) that lock the protein into a high activity state. In this report we examine the consequences of constitutive
PrfA activation on L. monocytogenes fitness both in vitro and in vivo. Whereas prfA* mutants were hyper-virulent during
animal infection, the mutants were compromised for fitness in broth culture and under conditions of stress. Broth culture
prfA*-associated fitness defects were alleviated when glycerol was provided as the principal carbon source; under these
conditions prfA* mutants exhibited a competitive advantage over wild type strains. Glycerol and other three carbon sugars
have been reported to serve as primary carbon sources for L. monocytogenes during cytosolic growth, thus prfA* mutants
are metabolically-primed for replication within eukaryotic cells. These results indicate the critical need for environment-
appropriate regulation of PrfA activity to enable L. monocytogenes to optimize bacterial fitness inside and outside of host
cells.
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Introduction
The environmental bacterial pathogen Listeria monocytogenes is an
intriguing example of a microorganism that has become well
adapted to life in the soil as well as to life within the cytosol of
mammalian host cells. This bacterium is widespread in the
environment where it is believed to live as a saprophyte on
decaying plant material [1]. Upon ingestion by a susceptible
mammalian host, L. monocytogenes transitions into a physiological
state that facilitates bacterial survival and replication within host
cells [2,3]. While disease caused by L. monocytogenes in healthy
individuals is usually restricted to a self-limiting gastroenteritis, in
immunocompromised individuals and pregnant women L. mono-
cytogenes is capable of causing systemic infections that lead to
meningitis, encephalitis, and in the case of pregnant women,
infection of the developing fetus leading to abortion, stillbirth, or
neonatal infections [4,5]. L. monocytogenes contamination of food
products has resulted in some of the most expensive food recalls in
U.S. history [2,6–12] and this is thought to reflect the bacterium’s
widespread environmental distribution and its ability to withstand
a variety of stress conditions [13–16].
A significant amount of research has focused on the mechanisms
used by L. monocytogenes to establish its replication niche within
mammalian host cells. L. monocytogenes invades a wide variety of cell
types and is capable of escaping from the phagosome following cell
entry, of replicating within the cytosol, and of utilizing host cell
actin polymerization machinery to propel itself through the cytosol
and into neighboring cells [3,5,17]. To survive and flourish within
eukaryotic cells the bacterium requires the regulated expression of
a number of secreted virulence factors, and the expression of most
of these gene products is regulated by a transcriptional regulator
known as PrfA [18]. PrfA is an essential regulator of L. monocytogenes
pathogenesis, and bacterial mutants that lack functional PrfA are
severely attenuated in animal infection models [19,20].
PrfA is a member of the Crp/Fnr family of transcriptional
activators, and members of this family appear to require post-
translational modification or the binding of a small molecule co-
factor for full activity [21–23]. PrfA activation occurs upon
bacterial entry into the host cell cytosol and is required for the
increased expression of gene products that promote bacterial cell-
to-cell spread [19,24–29]. L. monocytogenes strains that encode a
mutant form of prfA (prfA Y154C) whose product fails to become
activated following cytosol entry are severely attenuated for
virulence [30]. The signal that induces PrfA activation remains
unknown, however L. monocytogenes strains have been isolated that
contain mutations within prfA resulting in constitutive PrfA
activation (prfA* alleles) [31–36]. prfA* strains exhibit enhanced
invasion of host cells, rapid escape from the phagosome, and an
apparent increase virulence following intravenous injection of
mice [32,37]. In broth culture prfA* mutants exhibit the same high
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bacteria during intracellular growth [32,38–40]. While a number
of mutations have been identified in prfA that confer activation, the
absolute level of activation observed for different amino acid
substitution mutants can vary, with mutants exhibiting the highest
level of activation most closely resembling the levels of activation
observed for cytosolic bacteria [32–34,41,42].
Given that L. monocytogenes has evolved specific mechanisms to
regulate PrfA activity in response to environmental conditions
found inside and outside of host cells, we sought to determine the
impact of constitutive PrfA activation on the fitness of L.
monocytogenes by comparing the growth of strains in broth culture
and in tissue culture and mouse infection models. Our results
indicate that PrfA activity must be carefully modulated in response
to environmental signals so as to enable L. monocytogenes to optimize
bacterial fitness both inside and outside of the infected host.
Results
Constitutive activation of PrfA reduces the fitness of L.
monocytogenes in nutrient-rich broth
Until recently, it has proven difficult to construct isogenic L.
monocytogenes prfA* mutant strains containing the alleles that confer the
highest PrfA activity by standard methods. As a result, these high
activity prfA* mutations have been introduced into DprfA strains on
plasmids [30,31,34,40,43,44]. While these approaches have been
informative, there are associated caveats that include multicopy
plasmid effects or altered gene expression profiles resulting from the
use of integrated plasmids in ectopic locations. We recently reported
the successful construction of high activity prfA* isogenic mutants in
strains containing promoterless copies of the genes encoding b-
glucuronidase (gus) and neomycin resistance (neo) located in the
chromosome downstream of the PrfA-dependent gene actA [41].
Isogenic prfA* mutants constructed via allelic exchange were isolated
based on the PrfA*-dependent increase in actA-gus-neo expression that
enabled selection for prfA* colonies on selective media containing
neomycin and 5-bromo-4-chloro-3-indolyl-b-D-glucuronic acid (x-
gluc), a substrate for GUS activity. This approach now enables the
direct comparison of independently isolated L. monocytogenes prfA*
mutants with strains containing the wild type allele.
To assess if the constitutive activation of PrfA influences the
fitness of L. monocytogenes outside of host cells, strains containing
mid-level (prfA G155S) or high-level (prfA G145S and prfA L140F)
prfA* activity mutations [41] were compared with a wild type
strain for growth in BHI broth. Consistent with previous reports,
prfA* mutations conferred high levels of PrfA activity in broth
culture as indicated by actA expression levels (Fig. 1A). Expression
from the actA promoter for the prfA G155S and prfA G145S
mutants was 230-fold and 1870-fold higher respectively than the
levels observed for wild type prfA strains after 24 hours of growth
in BHI (Fig. 1A). Overall growth of the prfA* mutants was very
similar to that of the wild type strain, although the doubling times
of the prfA* mutants during logarithmic growth were slightly
longer (Table S1) and the final bacterial cell densities at stationary
phase were slightly lower in the prfA* monocultures than in the
wild type monocultures (Fig. 1B).
In contrast to monoculture growth, pronounced fitness effects
were observed for high activity prfA* strains when the mutants
were mixed and grown with wild type bacteria in BHI. Each prfA*
mutant exhibited a competitive defect when cultures were
inoculated in equal numbers with wild type bacteria and grown
to stationary phase with subsequent cycles of dilution and
outgrowth (Fig. 1C). After nine sequential cycles of overnight
growth and dilution, wild type bacteria were observed in two-fold
greater numbers in comparison to the mid-level prfA G155S
mutant and 200-fold greater numbers in comparison to the high-
level prfA G145S and prfA L140F mutant strains (Fig. 1C). A direct
correlation thus appeared to exist between the level of PrfA
activation conferred by a prfA* mutation and the magnitude of the
competitive defect observed in broth culture. In addition, the
identical phenotypes observed for independently derived prfA
G145S and prfA L140F strains confirmed that the observed defect
resulted from the mutational activation of prfA and did not reflect a
second site mutation; an additional independently derived prfA*
mutant (prfA Y63C) likewise exhibited an identical competitive
defect (J. Bruno, unpublished). Bacterial supernatants derived from
wild type cultures did not inhibit the growth of prfA* mutants (J.
Bruno, unpublished), indicating that there is no apparent
inhibitory substance produced by wild type bacteria that
compromised mutant growth.
To determine if the competitive defects exhibited by the prfA*
mutants occurred during logarithmic growth or whether the
defects were associated with entry into or survival during
stationary phase, mixed cultures were diluted into fresh BHI
upon reaching late-logarithmic phase (OD600 of 0.8–1.0), prior to
bacterial entry into stationary phase. When mixed cultures of wild
type and prfA G145S bacteria were grown under these conditions,
the resulting competitive defect was essentially identical to the
competitive defect observed for mixed cultures grown to stationary
phase (Fig. 1D). This indicates that constitutive activation of PrfA
impairs the competitive fitness of L. monocytogenes in broth culture
during logarithmic growth.
The presence of glucose exacerbates the competitive
defect exhibited by L. monocytogenes prfA* strains. It
has been previously reported that multicopy plasmid-based over-
expression of constitutively activated PrfA (prfA G145S) interferes
with bacterial utilization of glucose as a carbon source [43,44]. To
examine if isogenic prfA* mutants exhibited a fitness defect in the
presence of glucose, the prfA G145S mutant was grown in LB
buffered to pH 7.4 and supplemented with 55 mM of glucose. LB
was selected for monitoring growth as L. monocytogenes requires an
added carbon source for optimal growth in this medium. Similar
to the observations made for prfA* monocultures in BHI, cultures
grown in LB and glucose-supplemented LB resembled the wild
type strain with only subtle growth differences, indicating that the
isogenic prfA* strains were able to efficiently use glucose as a
carbon source (Fig. 2A and Table S1). However, when prfA G145S
cultures were mixed with the wild type strain and grown in LB or
in LB supplemented with glucose, the competitive defect exhibited
by the prfA G145S mutant in LB with glucose was of greater
magnitude than that exhibited in LB alone (Fig. 2B). After seven
cycles of dilution and outgrowth, wild type bacteria outnumbered
the prfA G145S mutants by 30-fold and 170-fold in LB and in
glucose-supplemented LB, respectively (Fig. 2B). The presence of
glucose thus exacerbated the competitive defect associated with
PrfA activation in broth culture.
Constitutive activation of PrfA increases the fitness of L.
monocytogenes in the presence of glycerol
Stoll et al. have reported that plasmid-based over-expression of
prfA* decreased the fitness of L. monocytogenes in the presence of
glycerol based on reduced growth in media where glycerol was the
main or sole carbon source [44]. To determine if isogenic prfA*
mutants were compromised for growth in the presence of glycerol,
the prfA G145S mutant was grown in LB buffered to pH 7.4 and
supplemented with 55 mM glycerol. Surprisingly, monocultures of
the prfA G145S mutant in glycerol-supplemented LB grew to five-
fold higher cell densities in comparison to wild type strains (Fig. 2A).
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exhibited a competitive advantage when it was mixed and grown
with wild type L. monocytogenes in glycerol-supplemented LB. After
seven cycles of dilution and outgrowth, prfA G145S outnumbered
wild type bacteria by more than 20-fold (Fig. 2B). These findings
indicate that constitutive activation of PrfA increases the fitness of L.
monocytogenes in the presence of glycerol. The findings further
indicate that competitive defects associated with the prfA* strains in
other media cannot simply be attributed to the metabolic burden of
increased PrfA-dependent gene product expression, as high
expression levels are maintained by prfA* strains in the presence
of glycerol ([44,45] and J. Bruno, unpublished).
Constitutive activation of PrfA increases the sensitivity of
L. monocytogenes to osmotic stress and acid stress
The ability of L. monocytogenes to withstand a variety of stresses is
vital for its survival and replication in disparate environments
[5,13,46,47], including food processing facilities [9,48] and the
gastrointestinal tract [3,17,49,50]. To determine if constitutive
activation of PrfA influences the ability of L. monocytogenes to
respond to stress, monoculture and mixed culture growth of the
prfA* mutants and wild type L. monocytogenes was examined under
two different stress conditions, osmotic stress and acid stress.
Although no dramatic differences were observed for mutant and
wild type strains with respect to growth in monoculture (Fig. 3AC),
the prfA G155S mutant and the prfA G145S mutant exhibited
more severe competitive defects when mixed with the wild type
strain and grown in BHI supplemented with 5% NaCl in
comparison to BHI lacking additional NaCl (Fig. 3B). After nine
cycles of dilution and outgrowth, wild type bacteria outnumbered
mutants by more than 150-fold (prfA G155S) and 200,000-fold
(prfA G145S) in the presence of additional NaCl, in comparison to
differences of 2-fold (prfA G155S) and 200-fold (prfA G145S) in
growth media lacking added NaCl (Fig. 3B).
Figure 1. prfA* mutants exhibit a competitive defect when grown with wild type in nutrient rich broth. (A) Comparison of levels of PrfA
activation between different prfA* mutantstrainsas measured by actA expression. PrfA-dependent actA expression levelswere measured by monitoring
the GUS activity of L. monocytogenes strains containing an actA-gus transcriptional fusion. Bacteria were grown in BHI at 37uC with shaking, and units of
GUS activity were normalized to CFU/mL. Each datum point represents the mean 6 standard deviation of a GUS assay measured in duplicate, and each
GUS activity profile is representative of 2 independent experiments. The prfA* mutants are referred to by their PrfA amino acid mutations. (B)
Monoculture growth of wild type, DprfA, and prfA* L. monocytogenes strains in BHI at 37uC with shaking. Each growth curve is representative of two
independent experiments. (C) prfA*mutants exhibit a competitive defect when grown with wild type L. monocytogenes. Wild type L. monocytogenes was
transformed with the integrative plasmid vector pPL2 to confer chloramphenicol resistance, andthen assessed for growthin BHI at 37uC in the presence
of chloramphenicol-sensitive test strains as indicated. Mixed cultures were subjected to repeated cycles of culture dilution and outgrowth every
24 hours into fresh BHI. The competitive index (CI) values of the mixed cultures were determined immediately prior to each dilution as described in
ExperimentalProcedures.Thedatarepresentthe means6standarderrorsofthreeindependent experiments.(D) ThecompetitivedefectofprfA*strains
occurs duringlogarithmic growth.AmixedcultureoftheprfA G145Smutantandthewildtypestrainwassubjectedtorepeatedcyclesofculturedilution
and outgrowth at late-log phase (OD600 of 0.8–1.0<8610
8–1610
9 CFU/mL) (indicated at ‘G145S - log’). CI values were determined immediately prior to
each dilution. The data represent the means 6 standard errors of two independent experiments.
doi:10.1371/journal.pone.0015138.g001
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the wild type and prfA G145S L. monocytogenes strains in buffered LB (pH 7.4) with and without 55 mM of either glucose (glu) or glycerol (gly) at 37uC
with shaking were determined by measuring CFU/mL at the specified time points. Each growth curve is representative of two independent
experiments. (B) The wild type cam
R strain was mixed with the chloramphenicol-sensitive prfA G145S mutant in buffered LB with and without 55 mM
of either glucose (glu) or glycerol (gly) at 37uC with shaking. Mixed cultures were subjected to repeated cycles of growth and dilution (1:100) into
fresh media every 24 hours. CI values were determined immediately prior to each dilution. The data represent the means 6 standard errors of three
independent experiments.
doi:10.1371/journal.pone.0015138.g002
Figure 3. Stress conditions exacerbate the competitive defects exhibited by prfA* mutants. (A) Monoculture growth curves of L.
monocytogenes strains in BHI supplemented with 5% NaCl at 37uC were determined by measuring CFU/mL at the specified time points. The growth
curves of wild type and prfA G145S L. monocytogenes in BHI without additional NaCl are included. (B) Competitive index of wild type cam
R strain
mixed with a chloramphenicol-sensitive prfA* mutant in BHI supplemented with 5% NaCl at 37uC. Mixed cultures were subjected to repeated cycles
of growth and dilution (1:100) into fresh media every 24 hours. CI values were determined immediately prior to each passage. The data represent the
means 6 standard errors of three independent experiments. (C) Monoculture growth curves of L. monocytogenes strains in BHI buffered to pH 7.4 or
pH 5.5 at 37uC were determined by measuring CFU/mL at the specified time points. (D) Competitive index of the wild type cam
R strain mixed with a
chloramphenicol-sensitive prfA* mutant in BHI buffered to pH 7.4 or 5.5 at 37uC. Mixed cultures were subjected to repeated cycles of growth and
dilution (1:100) into fresh media every 24 hours. CI values were determined immediately prior to each dilution. The data represent the means 6
standard errors of three independent experiments.
doi:10.1371/journal.pone.0015138.g003
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competitive defect under acid stress. When L. monocytogenes was
grown in unbuffered BHI broth at 37uC, the pH was observed to
decrease from approximately 7.2 to 6.0 after 24 hours of growth (J.
Bruno, unpublished). When grown with wild type L. monocytogenes
strains, the prfA G145S mutant initially exhibited a more severe
competitive defect in BHI buffered to pH 5.5 than in unbuffered
BHI. After three cycles of dilution and outgrowth, wild type
bacteria were present in 400-fold greater numbers than the prfA
G145S mutant in BHI pH 5.5 in comparison to 15-fold greater
numbers in unbuffered BHI (Fig. 3D). Interestingly, the large
competitive defect exhibited by the prfA G145S mutant during the
first three cycles of dilution and outgrowth in BHI pH 5.5 shifted
to a competitive advantage with subsequent cycles, reducing the
wild type advantage from 400-fold to 20-fold after nine cycles
(Fig. 3D). This ratio was similar to the ratio observed after nine
cycles of dilution and outgrowth in BHI buffered to pH 7.4
(Fig. 3D). These findings suggest that the prfA G145S mutant goes
through an adaptation or acid tolerance response [51] that
increases its tolerance to acid stress to wild-type levels or even
beyond. Overall, these findings indicate that constitutive activation
of PrfA impaired the ability of L. monocytogenes to respond to
osmotic stress as well as its initial response to acid stress conditions.
The impaired stress response of prfA* mutants does not
result from impaired function of the stress-associated
sigma factor, SigB
The exacerbated decrease in the bacterial fitness of prfA*
mutants when subjected to two different stress conditions
suggested that a general response related to stress tolerance may
be compromised by constitutive activation of PrfA. A central
regulatory component that contributes to the ability of L.
monocytogenes to survive various stress conditions is the alternative
RNA polymerase sigma factor SigB [16,52]. SigB contributes to
prfA expression [25], and several previous studies have suggested
the existence of functional overlap between SigB and PrfA in
regulating the expression of L. monocytogenes genes that contribute to
virulence and/or stress response [40,53–60]. While DsigB growth
in monoculture resembled that of the wild type strain (Supple-
mental Fig. S2), DsigB mutants exhibited a competitive defect
when mixed with the wild type strain in BHI, indicating that loss of
SigB function decreases the competitive fitness of L. monocytogenes
(Fig. 4). Interestingly, the magnitude of the competitive defect
exhibited by the DsigB mutant closely resembled that observed for
prfA G145S mutants in BHI (Fig. 4C).
To determine if the competitive defect associated with prfA*
strains was related to an impairment of SigB function, prfA G155S
DsigB and prfA G145S DsigB double mutants were tested in broth
competition assays. If PrfA* impairs SigB function, one would
anticipate that the magnitude of the competitive defect exhibited
by a prfA* DsigB double mutant would be equivalent to that
exhibited by either single mutant (Fig. 4A). If however the
magnitude of the competitive defect exhibited by a prfA* DsigB
double mutant was equivalent to the sum of the defects exhibited
by the prfA* and DsigB single mutants (Fig. 4A), this would suggest
that PrfA and SigB alter stress resistance through separate
pathways. The competitive defect of a prfA* DsigB double mutant
was found to be equivalent to the sum of the defects of the prfA*
and the DsigB single mutants, and the additive effect of prfA* and
DsigB in the double mutant strain was evident throughout the
course of mixed growth (Fig. 4BC). Therefore, the stress related
competitive defect associated with the constitutive activation of
PrfA appears distinct from the defect associated with the loss of
SigB function.
Constitutive activation of PrfA enhances L.
monocytogenes virulence following intravenous and
intragastric infection of mice
Previous studies have reported that the prfA* mutants with mid-
level PrfA activity (prfA G155S mutants) were fully virulent when
intravenously inoculated into mice based on the bacterial CFU
required for a 50% lethal dose (LD50) [32]. Consistent with this
observation, mice intravenously infected with 2610
4 CFU had
significantly higher numbers of prfA* bacteria (prfA G155S, prfA
G145S, and prfA L140F) recovered from the livers and spleens at
24 hours post-infection compared to those infected with wild type
bacteria (Fig. 5A) (the liver and spleen are the primary organ
targets for L. monocytogenes replication [5]). Although the difference
was not statistically significant at 48 hours post-infection, the
bacterial burdens of the livers and spleens from mice infected with
the prfA* mutant tended to be higher than in organs associated
with wild type infection (Fig. 5B and J. Bruno, unpublished). The
hyper-virulent phenotype of the prfA* mutants was more apparent
when the infectious dose was reduced by ten-fold to 2610
3 CFU;
the bacterial burdens of the livers and spleens from mice infected
with the prfA G145S mutant at 48 hours post-infection were
approximately 300-fold and 4.5-fold higher in liver and spleen
than those of mice infected with wild type bacteria (P,0.01 for
both organs) (Fig. 5B). In mixed infection, the prfA* mutants
consistently exhibited a competitive advantage over wild type
strains (Fig. 5C). The competitive index values determined for
each liver and spleen for intravenously infected mice at 48 hours
post-infection showed that, on average, 2- to 7-fold more prfA*
bacteria were recovered from each organ in comparison to wild
type (Fig. 5C).
Although constitutive activation of PrfA enhanced bacterial
infection following intravenous injection of mice, the increased
sensitivity to both osmotic stress and acid stress observed for the
mutant strains (Fig. 3) suggested that the virulence of the prfA*
mutants might be attenuated if administered orally, the more
natural route of infection. We therefore examined the conse-
quences of constitutive PrfA activation on the fitness of L.
monocytogenes within an animal host following intragastric inocula-
tion. Intragastric infection with either the prfA G145S mutant or
wild type L. monocytogenes strain was carried out following the
introduction of the inlA
m mutation into each strain background to
enhance bacterial interaction with mouse E-cadherin and
translocation of bacteria across the intestinal epithelium [61].
Surprisingly, 2- to 7-fold more bacteria were recovered from the
livers, spleens, stomachs, and intestines of mice infected with the
prfA G145S inlA
m mutant than from the organs of mice infected
with the wild type prfA inlA
m strain at infectious doses of either
5610
7 CFU or 5610
9 CFU (Fig. 6). These findings indicate that
constitutive activation of PrfA enhances the fitness of L.
monocytogenes inside of the host following either intravenous or
intragastric inoculation.
Discussion
Central to the ability of L. monocytogenes to flourish in a wide
variety of environments is the appropriate expression of gene
products that facilitate bacterial survival and replication within a
given niche. L. monocytogenes occupies disparate environments that
range from soil and food-processing plants to the gastrointestinal
tract and cell cytosol of infected mammals [3,5,9,13,17,46–50]. It
has been previously demonstrated that dramatic increases in PrfA
activity and PrfA-dependent gene expression occur following entry
of L. monocytogenes into the cytosol [18,42,62,63]. We therefore
sought to investigate the importance of appropriate regulation of
PrfA Activation Impacts L. monocytogenes Fitness
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context of L. monocytogenes fitness inside and outside of infected host
cells. Our results indicate that while constitutive activation of PrfA
serves to enhance bacterial virulence within the infected host, in
most cases PrfA activation decreases bacterial fitness outside of
host cells. L. monocytogenes therefore regulates PrfA activity so as to
optimally balance life in the outside environment with life inside of
the host.
Environmental regulation of PrfA activity suggests that the high
levels of PrfA activity required for intracellular life are detrimental
to the fitness of L. monocytogenes outside of a host cell, and limited
analyses of L. monocytogenes field strains appear to support this
Figure 4. The increased susceptibility of prfA* cultures to stress is unrelated to sigB function. (A) Rationale regarding how the
competitive defect exhibited by a prfA* DsigB double mutant can be used to determine if the competitive defect associated with constitutive PrfA
activation is related to an impairment of SigB function. If constitutive activation of PrfA (PrfA*) impairs SigB function, the magnitude of the
competitive defect exhibited by a prfA* DsigB double mutant strain will be equivalent to the magnitude of the competitive defects exhibited by the
prfA* and DsigB single mutants. If constitutive activation of PrfA (PrfA*) does not impair SigB function, the magnitude of the competitive defect
exhibited by a prfA* DsigB double mutant will be equivalent to the sum of the magnitudes of the competitive defects exhibited by the prfA* and
DsigB single mutants. (B) Assessment of the competitive index for the prfA G155S DsigB double mutant. The wild type cam
R strain was mixed with a
chloramphenicol-sensitive test strain in BHI at 37uC. Mixed cultures were subjected to repeated cycles of growth and dilution (1:100) into fresh BHI
every 24 hours, and CI values were determined immediately prior to each dilution. The data represent the means 6 standard errors of two
independent experiments. (C) Assessment of the competitive index for the prfA G145S DsigB double mutant. The wild type cam
R strain was mixed
with a chloramphenicol-sensitive test strain in BHI at 37uC. Mixed cultures were subjected to repeated cycles of growth and dilution (1:100) into fresh
BHI every 24 hours, and CI values were determined immediately prior to each dilution. The data represent the means 6 standard errors of two
independent experiments.
doi:10.1371/journal.pone.0015138.g004
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field strain reported in the literature has been found to contain a
prfA* mutation nor to exhibit a PrfA* phenotype; all of the prfA*
mutations reported have arisen spontaneously in laboratory media
or as a result of chemical mutagenesis [30–33,35,37]. Moreover,
field strains have been isolated containing missense mutations or
small deletions within the coding region of the prfA gene that
decrease or eliminate PrfA activity, indicating that PrfA activity is
not required for optimal bacterial fitness outside of a host cell
[64,65] although a recent report indicates that some activity is
required for efficient biofilm formation [66].
The link between carbon source utilization and PrfA regulation
of L. monocytogenes virulence gene products has long been
recognized but has remained poorly defined. Previous studies
have demonstrated that when L. monocytogenes was grown in the
presence of glucose or other carbon sources taken up by the
phosphoenolpyruvate (PEP) transport system (PTS), the expression
levels of PrfA-dependent genes were decreased [29,67,68]. Other
studies have reported that over expression of prfA* on a multicopy
plasmid in L. monocytogenes significantly impaired bacterial growth
and glucose uptake in media where glucose was the main or sole
carbon source [43,44]. Although the isogenic prfA* strains used in
Figure 5. Growth of the prfA* mutants in the livers and spleens of intravenously infected mice. 7–8 week old ND4 Swiss Webster mice
were infected with L. monocytogenes via tail-vein injections, and at the specified times post-infection (pi), the bacterial loads of the livers and spleens
were determined as described in Experimental Procedures. Data are presented as scatter dot plots, with horizontal bars representing means. (A)
Infection of mice with 2610
4 CFU wild type, prfA G155S, prfA L140F, or prfA G145S mutants. Organs were harvested 24 hours pi. Asterisks denote
statistically significant differences between the amounts of prfA* mutant and wild type CFU recovered using a one-way analysis of variance with
Dunnett’s post-test (*, P,0.05; ***, P,0.001). (B) Comparison of infection with 2610
3 or 2610
4 CFU of wild type and prfA G145S mutant. Organs
were harvested 48 hours pi. Asterisks denote statistically significant differences between the amounts of prfA G145S mutant and wild type CFU
recovered using an unpaired t test with a two-tailed P value (**, P,0.01). (C) Competitive index of wild type and prfA* strains. Prior to intravenous
injection, the wild type Erm
r reference strain and the indicated test strain were mixed 1:1 for a total bacterial suspension of 2610
4 CFU. For each
organ, the competitive index (CI) value (CI= test strain CFU/reference strain CFU) was determined as described in Experimental Procedures. Asterisks
denote statistically significant CI values compared to 1 using a one-sample t test with a two-tailed P value (*, P,0.05; **, P,0.01).
doi:10.1371/journal.pone.0015138.g005
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previously reported in the presence of glucose in monoculture,
the addition of glucose to LB was found to exacerbate the
competitive defect exhibited by the prfA G145S mutant in LB
(Fig. 2B). While differences related to prfA* copy number may
influence the ability of L. monocytogenes prfA* mutants to utilize
glucose, the results in either case indicate that the presence of
glucose decreases the fitness of L. monocytogenes when PrfA is
activated.
In addition to the glucose-related growth defects reported for L.
monocytogenes strains containing multicopy plasmid-encoded prfA*,i t
has also been reported that similar strains exhibited a subtle
monoculture growth defect when grown in media where glycerol (a
non-PTS carbon source) was the main carbon source [44]. In
contrast to this finding, our data indicate that isogenic prfA* mutants
were enhanced for glycerol utilization and exhibited a competitive
advantage over wild type in the presence of glycerol (Fig. 2). While
the competitive advantage was evident during the first three cycles
of culture dilution and outgrowth, the wild type strain appeared to
adapt to glycerol as a carbon source such that bacterial mutant to
wild type ratios became stable after three cycles of growth (Fig. 2).
Consistent with an adaptation of wild type L. monocytogenes to growth
with glycerol, it was observed that after five cycles of dilution and
outgrowth monocultures of wild type bacteria in LB glycerol
reached the same cell densities as did the isogenic prfA* mutants but
retained low levels of PrfA-dependent gene expression (J. Bruno,
unpublished). L. monocytogenes prfA* strains thus appear to exist in a
metabolic state that favors bacterial growth in glycerol but not
glucose. The prfA* metabolic shift might thus enhance bacterial
growth in the cytosol, where three carbon sugars have been
suggested to be preferentially used for bacterial replication [69,70].
In addition to the PrfA*-related metabolic shift of L.
monocytogenes towards glycerol utilization, our data indicate that
the competitive defects exhibited by prfA* mutants in broth culture
were exacerbated under conditions of osmotic and/or acid stress
(Fig. 3). Based on the reports of functional overlap of SigB and
PrfA in regulation of L. monocytogenes gene expression [40,53–60]
and the fact that SigB is one of the most characterized stress
response regulators of L. monocytogenes [52], it seemed logical to
investigate whether the stress-associated fitness defects exhibited
by the prfA* mutants were related to alterations in SigB function.
Examination of the fitness of prfA* DsigB double mutant strains in
BHI indicated that the double mutant exhibited a competitive
defect that was approximately equivalent to the sum of the
competitive defects exhibited by the prfA* and DsigB single mutants
(Fig. 4). Thus, while constitutive PrfA activation appears to
interfere with the stress response of L. monocytogenes, it does so
independently of SigB. It is possible that PrfA activation may
somehow interfere with the function of another general stress
response factor, such as ClpC, whose expression has been shown
previously to be influenced by PrfA activity [71,72]. Alternatively,
constitutive activation of PrfA may interfere with the expression or
function of a factor(s) whose activity is directly involved in the
repair of a stress associated cell injury.
In contrast to bacterial fitness in culture media, the need for
down-regulation of PrfA activity does not appear to be required
within the infected host. Experiments with either intravenously or
intragastrically infected mice indicated that the prfA* mutants were
more virulent than wild type L. monocytogenes. More bacteria were
recovered from the livers and spleens of mice infected with prfA*
mutant bacteria compared to those infected with wild type bacteria,
and the mutant strains exhibited a competitive advantage in mixed
infections (Figs. 5 and 6). One surprising finding was that despite an
increased susceptibility to osmotic and acid stresses in culture media
(Fig. 3), the prfA* mutants remained hyper-virulent following oral
infection (Fig. 6).The GI tract presents L. monocytogenes with a variety
of stresses, including acid and osmotic stress [49] as well as stress
associated with mucousbarriers[73].Given that SigB contributesto
the gastrointestinal survival of L. monocytogenes [57,74] and that SigB
function does not appear to be affected by constitutive PrfA
activation (Fig. 4), prfA* mutants have the ability to respond to the
stresses of the GI tract via SigB. In addition, the PrfA*-dependent
increase in gene products that facilitate bacterial invasion (for
example, InlA, InlB, LLO, ActA) [5,18,62,75–79] and/or bile
resistance (Bsh, BilE) [54,55] may enhance intestinal translocation
so as to counter balance any stress-associated defects.
In summary, the findings presented in this study emphasize the
critical need for L. monocytogenes to regulate PrfA activity dependent
Figure 6. Growth of wild type prfA inlA
m and prfA G145S inlA
m strains in intragastrically infected mice. 8–10 week old C57BL/6 mice were
infected with (A)5 610
7 CFU or (B)5 610
9 CFU L. monocytogenes via intragastric injection and 72 hours post-infection the bacterial loads of the livers,
spleens, stomachs, and intestines were determined as described in Experimental Procedures. Data are presented as scatter dot plots, with horizontal
bars representing the means. The log (CFU/organ) value of 1.996 is the limit of detection and is represented by a dashed line. A datum point on the
dashed line represents an organ from which no detectable CFU were obtained. Asterisks denote statistically significant differences between the
amounts of prfA G145S mutant and wild type CFU recovered using an unpaired t test with a two-tailed P value (*, P,0.05; ***, P,0.001).
doi:10.1371/journal.pone.0015138.g006
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indicate a competitive fitness defect for prfA* mutants, it remains
possible that PrfA activation contributes to L. monocytogenes outside
of mammalian infection, for example by promoting bacterial
survival in the presence of lower eukaryotes or other soil dwellers.
PrfA activation clearly enhances bacterial virulence in mammalian
hosts, however the need for down modulation of PrfA activity in
other settings might well be a reflection of the yin-yang nature of
the L. monocytogenes saprophyte-pathogen balance.
Materials and Methods
Bacteria and culture media
The bacterial strains and plasmids used in this study are listed in
Table 1. All L. monocytogenes strains used were derived from the 1/
2a serotype 10403S L. monocytogenes strain, which is a streptomycin-
resistant derivative of strain 10403 [80,81]. The phenotypes
reported for strains containing prfA* mutations were verified in
independent isolates constructed by allelelic exchange and/or by
phage transduction, and by comparison of different prfA* alleles
(prfA G145S, prfA L140F, prfA Y63C). L. monocytogenes strains were
grown in brain heart infusion (BHI) (Difco Laboratories, Detroit,
MI) or Lysogeny Broth (LB) (Invitrogen Corp., Grand Island, NY).
Escherichia coli strains were grown in LB. When appropriate, LB
was supplemented with 55 mM of either glucose or glycerol. To
decrease or increase medium acidity, BHI or LB was buffered to
pH 7.4 with 100 mM of 3-(N-morpholino)propanesulfonic acid
(MOPS) pH 7.4 (Sigma Chemical Co., St. Louis, MO) or to
pH 5.5 with 100 mM of 2-(N-morpholino)ethanesulfonic acid
(MES) pH 5.5 (Sigma), respectively. To increase medium
osmolarity, BHI was supplemented with 5% sodium chloride
(NaCl). The antibiotics (and concentrations) used in this study
were: neomycin (5 mg/mL), chloramphenicol (10 mg/mL), eryth-
romycin (1 mg/mL), and streptomycin (200 mg/mL).
Construction of L. monocytogenes mutant strains via
bacteriophage transduction
L. monocytogenes strain NF-L1775 (prfA G145S DsigB) was
constructed by bacteriophage transduction as previously described
[33,82,83]. Briefly, 10
7–10
8 PFU of Listeria phage U153 lysates
[82] prepared from NF-L1177 (prfA G145S actA-gus-neo-plcB) [41]
were mixed with 10
8 CFU of mid-log FSL A1-254 (DsigB, a kind
gift of Dr. Kathryn Boor, Cornell University, Ithaca, NY) [84].
The prfA G145S DsigB double mutant was confirmed to contain
both the prfA G145S mutation and the downstream actA-gus-neo-
plcB transcriptional fusion from the prfA G145S mutant [41] by
isolating transductants that exhibited neomycin resistance and a
blue colony appearance on BHI agar containing 50 mg/ml 5-
bromo-4-chloro-3-indolyl-b-D-glucuronic acid (x-gluc).
Construction of L. monocytogenes mutant strains via
allelic exchange
L. monocytogenes strains NF-L1774 (prfA G155S DsigB), NF-L1772
(inlA
m), and NF-L1773 (prfA G145S inlA
m) were constructed using
derivatives of the temperature-sensitive integration vector pKSV7
Table 1. Bacterial strains and plasmids used in this study.
Strain Description/Genotype Designation Reference
TOP10,
SM10
E. coli strains for constructing recombinant plasmids
NF-L100 10403S wild type [80,81]
NF-L890 NF-L100 DprfA [33]
NF-L476 NF-L100 actA-gus-plcB [89]
NF-L1124 NF-L100 actA-gus-neo-plcB WT 10403S [30]
NF-L1123 NF-L890 actA-gus-neo-plcB DprfA [30]
NF-L943 NF-L476 prfA G155S prfA G155S [32]
NF-L1177 NF-L1124 prfA G145S prfA G145S [41]




NF-E1613 TOP10 with pTJA-57
FSL A1-254 10403S DsigB DsigB [84]
NF-L1774 NF-L943 DsigB prfA G155S DsigB This study
NF-L1775 NF-L1177 DsigB prfA G145S DsigB This study
DP-L3903 10403S with Tn917 insertion WT erm
R [90]
NF-E1458 E. coli with HEL-913 [38]
NF-L1772 NF-L1124 inlA
S192N,Y369S WT 10403S inlA
m This study
NF-L1773 NF-L1177 inlA
S192N,Y369S prfA G145S inlA
m This study
Plasmid Description/Genotype Reference
pPL2 Site-specific phage integration vector [87]
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m mutation enhances the intestinal translocation of L.
monocytogenes but has no impact on the outcome of intravenous
infection [61]. Plasmid vector pTJA-57 (pKSV7::DsigB, kind gift of
Dr. Kathryn Boor) [84], a pKSV7 derivative designed for the
construction of DsigB mutations, was introduced into NF-L943
(prfA G155S) by electroporation as previously described [86].
Chromosomal integration of pTJA-57 and subsequent allelic
exchange and plasmid curing were carried out as previously
described [85]. The introduction of the DsigB mutation into the
prfA G155S mutant background was confirmed by PCR
amplification of the sigB open reading frame using primers
LmsigB-15 and LmsigB-16 [84] (Table 2).
To facilitate the investigation of intragastric infections of mice,
the inlA
m (inlA
S192N,Y369S) mutation described by Wollert et al. [61]
was introduced into a wild type 10403S strain (NF-L1124) and the
prfA G145S mutant by electroporation, allelic exchange, and
plasmid curing of the plasmid vector pHEL-913 (pKSV7-inlA
m,a
kind gift of Dr. Helene Marquis, Cornell University, Ithaca, NY)
[38]. Strains NF-L1772 (inlA
m) and NF-L1773 (prfA G145S, inlA
m)
were generated. The introduction of the inlA
m mutation was
confirmed by PCR amplification and DNA sequencing of the inlA
open reading frame using primers MARQ403 and MARQ408
[38] (Table 2).
Monoculture growth experiments
50 mL or 100 mL of an overnight culture grown in BHI were
added to 12.5 mL or 25 mL, respectively, of fresh broth culture
medium (a 1:250 dilution) and incubated at 37uC with vigorous
shaking and aeration. At specified time points, the optical density
at 600 nm (OD600) of the culture was measured using a BioMate 3
UV-Vis Spectrophotometer (Thermo Fisher Scientific, Inc.,
Waltham, MA) and CFU/mL were determined by plating
dilutions of a culture aliquot on BHI agar.
Broth culture mixing experiments
The experimental design to assess the competitive index of a
mixed bacterial broth culture is depicted in Figure S1. Briefly,
equal amounts of bacteria from overnight cultures of wild type
10403S (reference strain) and a mutant or test strain grown in BHI
were mixed at a 1:250 dilution into a fresh BHI broth (or the
indicated culture medium). To differentiate between the strains,
the wild type 10403S reference strain contained the single copy
integration plasmid pPL2 [87] to confer chloramphenicol
resistance (designated WT cam
R strain in Table 1). Repeating
cycles of culture growth and dilution (referred to as serial passages)
were used to assess the competitive fitness of the test strain in
comparison to wild type under a specific growth condition. Mixed
cultures were incubated for 24 hours at 37uC with shaking and
aeration and then diluted 1:100 into fresh culture media and again
grown for 24 hours at 37uC with shaking followed by a 1:100
dilution. A total of nine cycles of growth and dilution (or 9
passages) were carried out in each serial-passage regime.
Immediately prior to each dilution an aliquot of the mixed culture
was removed, diluted, and plated onto BHI agar to obtain
bacterial CFU counts. 150 of the resulting colonies were then
patched onto BHI agar containing chloramphenicol to select for
wild type cam
R bacteria. The competitive index (CI) value of the
mixed culture was determined using the following equation: CI=
(test strain CFU)/(WT cam
R reference strain CFU). When the test
strain was resistant to an antibiotic to which the WT cam
R
reference strain was sensitive, aliquots were also plated on BHI
agar containing the appropriate antibiotic. For example, the prfA
G145S mutant is neomycin-resistant because of the actA-gus-neo-
plcB transcriptional fusion it contains, but the WT cam
R strain is
neomycin-sensitive, so aliquots from mixed cultures of the prfA
G145S and WT cam
R strains were also plated on BHI agar
containing neomycin. For graphic representation, the CI value of
a mixed culture was plotted as a function of the mixed culture’s
dilution cycle number or passage number (passage #,P #), with
‘passage 0’ representing the initial mixture of two monocultures,
‘passage 1’ representing the mixed culture after the initial 24 hours
of growth immediately prior to the first passage, ‘passage 2’
representing the mixed culture after the 24 hours of growth
following the first passage and immediately prior to the second
passage, etc. (Figure S1). pPL2 integration did not affect the
competitive index of wild type 10403S in any growth condition as
the WT cam
R strain never exhibited a competitive advantage nor
disadvantage when mixed with the 10403S strain lacking the pPL2
inserted plasmid (CI values of ,1 throughout the course of a
mixing experiment) (Fig. 1C and J. Bruno, unpublished).
Measurement of b-glucuronidase (GUS) activity
GUS activity was measured by an enzymatic assay as previously
described [88]. Briefly, overnight cultures grown in BHI were
diluted 1:50 into fresh media and grown with shaking at 37uC.
CFU/mL were measured at specified time points and two 500 mL
culture aliquots were collected (for the prfA G145S and prfA L140F
mutants, two 50 mL culture aliquots were collected because of
their increased actA-gus expression) [41]. The aliquots were
centrifuged (16,1006g) for 5 minutes, supernatants were removed,
and one pellet from the two aliquots was suspended in 100 mLo f
ABT buffer (0.1 M potassium phosphate, pH 7.0, 0.1 M NaCl,
0.1% Triton) while the other was suspended in 1 mL of ABT
buffer. Two 50 mL aliquots of each ABT bacterial suspension were
pipetted into separate wells of a 96-well plate. 10 mL of 0.4 mg/
mL of the GUS substrate 4-methylumbelliferyl-b-D-glucuronide
(Sigma) were added to each 50 mL aliquot, and these mixtures
were incubated at 37uC for 60 minutes. Substrate conversion was
measured with a Barnstead/Turner Quantech FM109515 Fluo-
rometer (Dubuque, IA). Units of GUS activity were calculated as
previously described [88].
Intravenous infections of mice
Animal procedures were IACUC approved by the UIC Animal
Care Committee (Approval #09-153) and performed in the
Biological Resources Laboratory at the University of Illinois at
Chicago. Mid-log L. monocytogenes growing in BHI were washed,
suspended, and diluted in PBS to reach a final concentration of
1610
4 CFU/mL or 1610
5 CFU/mL. 7–8 week old ND4 Swiss
Webster mice (Harlan Laboratories, Inc., Madison, WI) were
infected via tail vein injections with 200 mL of the bacterial
suspensions, achieving an infectious dose (ID) of 2610
3 CFU or
2610
4 CFU, respectively. 24 or 48 hours post infection, the mice
were sacrificed, and their livers and spleens were harvested. Each
organ was placed in 5 mL of sterile Milli-Q water and
homogenized with a Tissue Master-125 Watt Lab Homogenizer
Table 2. Oligonucleotides used in this study.
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diluted and plated on BHI agar containing streptomycin to
determine CFU/organ.
Oral infections of mice
Mid-log L. monocytogenes growing in BHI were washed,
suspended, and diluted in PBS to reach a final concentration of
2.5610
8 CFU/mL or 2.5610
10 CFU/mL. 8–10 week old
C57BL/6 mice (Harlan) were infected orally with 200 mL of the
bacterial suspensions, achieving an ID of 5610
7 CFU or
5610
9 CFU, respectively. 72 hours post infection, mice were
sacrificed, and their livers, spleens, stomachs, and intestines were
harvested. The organs were homogenized and their bacterial loads
were determined as described above.
Supporting Information
Table S1 Logarithmic doubling times of L. monocytogenes strains
under various conditions at 37uC. (DOC)
Figure S1 Experimental design of the broth culture mixing
experiments. A detailed explanation is provided in Experimental
Procedures    .  (TIF)
Figure S2 Growth curves of L. monocytogenes strains in BHI at
37 ¯C were determined by measuring CFU/mL at the specified
time points. The growth curves of wild type, prfA G155S, and prfA
G145S L. monocytogenes in BHI are included (Fig. 1B). (TIF)
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